Skip to the content
  • Home
  • Care Areas
        • Lung Cancer
        • Tuberculosis
        • Neurocritical Care
        • Who We Help
  • Products
        • qXRAI for Chest X-rays
        • qERAI for Head CTs
        • qCT-LungAI for Chest CTs
        • qVHAI for Ultrasound
        • qMSKAI for Musculoskeletal X-rays
        • qTrackEnd-to-End Disease Management Platform
        • qRemoteStreamlining Patient-care Workflows for Early Intervention
        • How we deploy
        • Information Security and Medical Device Regulation
  • Our Impact
  • Evidence
  • Blog
  • About Us
    • Our Company
    • Newsroom
  • Contact Us
  • Try now
Qure AIQure AI
    • Home
    • Care Areas
          • Lung Cancer
          • Tuberculosis
          • Neurocritical Care
          • Who We Help
    • Products
          • qXRAI for Chest X-rays
          • qERAI for Head CTs
          • qCT-LungAI for Chest CTs
          • qVHAI for Ultrasound
          • qMSKAI for Musculoskeletal X-rays
          • qTrackEnd-to-End Disease Management Platform
          • qRemoteStreamlining Patient-care Workflows for Early Intervention
          • How we deploy
          • Information Security and Medical Device Regulation
    • Our Impact
    • Evidence
    • Blog
    • About Us
      • Our Company
      • Newsroom
    • Contact Us
    • Try now
  • Evidence suggests that certain types of plaques have a higher risk of CVD within ~3-6 months. For such plaques, medications such as sglt2 inhibitors, pcsk9 inhibitors, statins, and anti-platelets have demonstrated the ability to alter the plaque characteristics and prevent any critical event.
  • qVH helps identify asymptomatic patients with such plaque characteristics and estimates a dynamic CVD risk score that helps manage the patient’s health with different treatment protocols.

Featured in

Subscribe to our Newsletter

Stay up to date with the latest news from Qure.ai

Qure.ai Technologies Private limited

Qure.ai was founded in 2016. Our mission is to use artificial intelligence to make healthcare more accessible and affordable.

Follow Us

Products

  • qXR
  • qER
  • qCT-Lung
  • qVH
  • qMSK
  • qTrack
  • qRemote

Care Areas

  • Lung Cancer
  • Tuberculosis
  • Neurocritical Care
  • Who We Help

About

  • Our Company
  • Newsroom
  • Legal
  • Evidence
  • Our Impact
  • Blog
  • Contact Us

Privacy Policy

Information Security and Medical Device Regulation

CIN U74999MH2016PTC283891   |   © 2022 Qure.ai